Beta vulgaris var. cicla methanol extract prevents the formation of advanced glycation end products and protein oxidation against -glucose, and -fructose-induced protein glycation in vitro
Keywords:Beta vulgaris, Glycation, Glucose, Fructose, Protein oxidation
Beta vulgaris is an edible plant and herbal medicine traditionally used to treat diabetes and breast cancer and protect against liver damage induced by an HF diet. The aim of this investigation to evaluate the inhibitory activity of B. vulgaris (CH) extract on the formation of advanced glycation end products (AGEs) against fluorescent and Non-fluorescent AGEs, protein oxidation, and protein aggregation in an in vitro model of glucose and fructose protein glycation and Congo red test. Our study provides evidence that CH significantly reduced fluorescent and no fluorescent (Nε-CML) and fructosamine levels in AGEs-BSA systems during four weeks of study. It also avoided protein oxidation, which was shown by the depletion of protein thiol and reduced protein carbonyl, preventing structural loss of protein and AGEs formation by inhibiting protein oxidation and protein glycation. Furthermore, CH extract also inhibited amyloid cross β-structure and increased GPx enzymatic activity. This study demonstrated that CH has a noticeable antiglycation effect in a varied glycation modification of albumin and can retard or forewarn AGEs-related diabetes type 2.
How to Cite
Copyright (c) 2022 International Journal of Ayurvedic Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.
This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.
The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.